Home/Filings/4/0001209191-18-011354
4//SEC Filing

GORELICK RICHARD D. 4

Accession 0001209191-18-011354

CIK 0000917520other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:29 PM ET

Size

9.1 KB

Accession

0001209191-18-011354

Insider Transaction Report

Form 4
Period: 2018-02-15
GORELICK RICHARD D.
Corp VP, Gen Counsel & Sec
Transactions
  • Award

    Common Stock

    2018-02-15+2,00724,616 total
  • Award

    Common Stock

    2018-02-15+1,04422,609 total
  • Award

    Common Stock

    2018-02-15+1,78326,399 total
Footnotes (3)
  • [F1]On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least a 3% increase in annual revenue over the prior fiscal year, under the March 23, 2015 Performance Stock Award. Accordingly, 34% of the shares will vest on March 23, 2018, the third anniversary of the grant date.
  • [F2]On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 33% of the shares will vest on March 14, 2018 at 150% target, the second anniversary of the grant date.
  • [F3]On February 15, 2018, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2017, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2018 at 150% target, the first anniversary of the grant date.

Issuer

INTEGRA LIFESCIENCES HOLDINGS CORP

CIK 0000917520

Entity typeother

Related Parties

1
  • filerCIK 0001563554

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:29 PM ET
Size
9.1 KB